180 related articles for article (PubMed ID: 1717120)
21. Is cyclic AMP involved in excitatory amino acid-evoked adenosine release from rat cortical slices?
Craig CG; Temple SD; White TD
Eur J Pharmacol; 1994 Sep; 269(1):79-85. PubMed ID: 7530209
[TBL] [Abstract][Full Text] [Related]
22. The effects of elevated cyclic AMP levels on histamine-H1-receptor-stimulated inositol phospholipid hydrolysis and calcium mobilization in the smooth-muscle cell line DDT1MF-2.
Dickenson JM; White TE; Hill SJ
Biochem J; 1993 Jun; 292 ( Pt 2)(Pt 2):409-17. PubMed ID: 8389134
[TBL] [Abstract][Full Text] [Related]
23. Regulation of cyclic AMP metabolism in bovine adrenal medullary cells.
Marley PD; Thomson KA
Biochem Pharmacol; 1992 Dec; 44(11):2105-10. PubMed ID: 1335250
[TBL] [Abstract][Full Text] [Related]
24. Morphine, capsaicin and K+ release purines from capsaicin-sensitive primary afferent nerve terminals in the spinal cord.
Sweeney MI; White TD; Sawynok J
J Pharmacol Exp Ther; 1989 Jan; 248(1):447-54. PubMed ID: 2492344
[TBL] [Abstract][Full Text] [Related]
25. Involvement of adenosine in the spinal antinociceptive effects of morphine and noradrenaline.
Sweeney MI; White TD; Sawynok J
J Pharmacol Exp Ther; 1987 Nov; 243(2):657-65. PubMed ID: 2824755
[TBL] [Abstract][Full Text] [Related]
26. Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells.
Pan X; Arauz E; Krzanowski JJ; Fitzpatrick DF; Polson JB
Biochem Pharmacol; 1994 Aug; 48(4):827-35. PubMed ID: 7521642
[TBL] [Abstract][Full Text] [Related]
27. Morphine-evoked release of adenosine from the spinal cord occurs via a nucleoside carrier with differential sensitivity to dipyridamole and nitrobenzylthioinosine.
Sweeney MI; White TD; Sawynok J
Brain Res; 1993 Jun; 614(1-2):301-7. PubMed ID: 8348322
[TBL] [Abstract][Full Text] [Related]
28. Cardiotonic actions of selective phosphodiesterase inhibitors in rat isolated ventricular cardiomyocytes.
Kelso EJ; McDermott BJ; Silke B
Br J Pharmacol; 1993 Dec; 110(4):1387-94. PubMed ID: 8306078
[TBL] [Abstract][Full Text] [Related]
29. Antidepressant properties of some phosphodiesterase inhibitors.
Przegaliński E; Bigajska K
Pol J Pharmacol Pharm; 1983; 35(3):233-40. PubMed ID: 6194518
[TBL] [Abstract][Full Text] [Related]
30. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
Kumari M; Cover PO; Poyser RH; Buckingham JC
Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
[TBL] [Abstract][Full Text] [Related]
31. Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3', 5'-monophosphate phosphodiesterase inhibitors.
Wachtel H
Psychopharmacology (Berl); 1982; 77(4):309-16. PubMed ID: 6182575
[TBL] [Abstract][Full Text] [Related]
32. Bradykinin inhibition of cyclic AMP accumulation in D384 astrocytoma cells. Evidence against a role of cyclic GMP.
Altiok N; Fredholm BB
Neurochem Int; 1992 Sep; 21(2):209-13. PubMed ID: 1284620
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators.
Derian CK; Santulli RJ; Rao PE; Solomon HF; Barrett JA
J Immunol; 1995 Jan; 154(1):308-17. PubMed ID: 7995950
[TBL] [Abstract][Full Text] [Related]
34. Evidence that the presynaptic A2a-adenosine receptor of the rat motor nerve endings is positively coupled to adenylate cyclase.
Correia-de-Sá P; Ribeiro JA
Naunyn Schmiedebergs Arch Pharmacol; 1994 Nov; 350(5):514-22. PubMed ID: 7870191
[TBL] [Abstract][Full Text] [Related]
35. Control of cyclic AMP levels in primary cultures of human tracheal smooth muscle cells.
Hall IP; Widdop S; Townsend P; Daykin K
Br J Pharmacol; 1992 Oct; 107(2):422-8. PubMed ID: 1384913
[TBL] [Abstract][Full Text] [Related]
36. Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro.
Alves AC; Pires AL; Cruz HN; Serra MF; Diaz BL; Cordeiro RS; Lagente V; Martins MA
Eur J Pharmacol; 1996 Sep; 312(1):89-96. PubMed ID: 8891583
[TBL] [Abstract][Full Text] [Related]
37. Role of adenosine 3',5'-cyclic monophosphate in adrenoceptor-mediated control of 3H-noradrenaline secretion in guinea-pig ileum myenteric nerve terminals.
Alberts P; Ogren VR; Sellström AI
Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):114-20. PubMed ID: 2413372
[TBL] [Abstract][Full Text] [Related]
38. Involvement of cyclic AMP in the effects of phosphodiesterase IV inhibitors on arachidonate release from mononuclear cells.
Hichami A; Boichot E; Germain N; Legrand A; Moodley I; Lagente V
Eur J Pharmacol; 1995 Oct; 291(2):91-7. PubMed ID: 8566180
[TBL] [Abstract][Full Text] [Related]
39. Selective phosphodiesterase inhibitors modulate the activity of alveolar macrophages from sensitized guinea-pigs.
Germain N; Bertin B; Legendre A; Martin B; Lagente V; Payne A; Boichot E
Eur Respir J; 1998 Dec; 12(6):1334-9. PubMed ID: 9877487
[TBL] [Abstract][Full Text] [Related]
40. Effects of cyclic AMP analogues and phosphodiesterase inhibitors on K+-induced [3H]noradrenaline release from rat brain slices and on its presynaptic alpha-adrenergic modulation.
Wemer J; Schoffelmeer AN; Mulder AH
J Neurochem; 1982 Aug; 39(2):349-56. PubMed ID: 6283025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
